Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
ASTRO
Feb 27, 2024, 05:01 |
Blog
Misty Shields: A “Master Class” on RPA in SCLC by Shadia I Jalal
Misty Shields, Assistant Professor at Indiana University School of Medicine, shared on X/Twitter: “A “Master…
Feb 25, 2024, 15:01 |
Insight
Arndt Vogel: Impressive and comprehensive review on BRAF mutations
Arndt Vogel shared on X/Twitter: "BRAF — a tumor-agnostic drug target with lineage-specific dependencies. Impressive…
Feb 24, 2024, 11:20 |
Blog
Mark Lewis: Delayed gastric emptying is MISERABLE
Mark Lewis, the Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, shared an X…
Feb 22, 2024, 23:27 |
Blog
Amalya Sargsyan: First approved T cell therapy for solid tumors
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, shared a post by Nicholas Restifo,…
Feb 19, 2024, 09:20 |
Insight
Brandon Huffman: Exciting translational work happening at Dana-Farber Cancer Institute
Brandon Huffman, Medical Oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, shared an…
Feb 16, 2024, 15:59 |
Blog
Kristen Ciombor: Please give us input on the role ASCO should play in clinical research!
Kristen Ciombor, Gastrointestinal Medical Oncologist at Vanderbilt, shared a post by Sandip Patel, Medical Oncologist…
Feb 15, 2024, 18:35 |
Insight
Nina Niu Sanford: The best way to advocate for radiotherapy is through better evidence demonstrating the value of our modality
Nina Niu Sanford, Assistant Professor of Radiation Oncology at UT Southwestern Medical Center, shared an…
Feb 14, 2024, 18:02 |
Blog
Mark Lewis: Dr. Andrew Ko’s observation at ASCO23 that orders of magnitude separate the cost of NALIRIFOX vs FOLFIRINOX!
Mark Lewis shared on X: “Seems relevant to resurface Dr. Andrew Ko’s observation at ASCO23…
Feb 14, 2024, 14:59 |
Blog
Yelena Janjigian is leading the investigator-initiated trial of the First Novel Combination of MiNK's Allogeneic Cell Therapy with Agenus' BOT/BAL
Today MiNK Therapeutics released an announcement of the First Refractory Gastric Cancer Patient Dosed in…
Feb 12, 2024, 17:46 |
Blog
Laura Vater: This is how compassion is taught
Laura Vater, Gastrointestinal Oncologist at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center,…
89
90
91
92
93
All:
1087
Posts:
901 - 910
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO 24: 15 Posts Not to Miss From Day 2
Julia Louis-Dreyfus and Breast Cancer: How She Went Against, How She Survived, and More
ASTRO24: 20 Posts Not To Miss From Day 1
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube